Besides mutations in the BMPR2 gene, mutations in the genes of other BMP signaling components (such as GDF-2, ACVRL1, ENDOGLIN, and SMAD8) have also been linked to PAH development [11, 53–59]. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.